Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis
Go back to Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1138.28 +22.58 (2.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1115.70 | 52 Week High | $88.16 | |||
| Open | $1142.20 | 52 Week Low | $67.88 | |||
| Day High | $1153.95 | P/E | 263.49 | |||
| Day Low | $1130.50 | EPS | $4.32 | |||
| Volume | 2,175,508 | |||||
